Paper29698587
Selective induction of cancer cell death by VDAC1-based peptides and their potential use in cancer therapy.
Shteinfer-Kuzmine A and 4 others. Mol Oncol, 2018. Cited by 51 papers, by iCite.
Cite this record
ConductScience Library. Selective induction of cancer cell death by VDAC1-based peptides and their potential use in cancer therapy. Papers, record 29698587. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29698587
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Selective induction of cancer cell death by VDAC1-based peptides and their potential use in cancer therapy.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Neoplasms | Major topic |
| Peptides | Major topic |
| Voltage-Dependent Anion Channel 1 | Major topic |
| Adenosine Triphosphate | |
| Amino Acid Sequence | |
| Animals | |
| Biomarkers, Tumor | |
| Calcium | |
| Cell Death | |
| Cell Line, Tumor | |
| Cell Proliferation | |
| Dogs | |
| Humans | |
| Mice | |
| Neoplastic Stem Cells | |
| Receptors, Transferrin | |
| Xenograft Model Antitumor Assays |
Source PubMed
References71
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 25448878 | The mitochondrial voltage-dependent anion channel 1 in tumor cells. | Biochim Biophys Acta | 2015 | https://conductscience.org/library/papers/25448878 | PubMed |
| 2 | 21827736 | Transmembrane helix-helix interactions are modulated by the sequence context and by lipid bilayer properties. | Biochim Biophys Acta | 2012 | https://conductscience.org/library/papers/21827736 | PubMed |
| 3 | 18347186 | Synergistic antipancreatic tumor effect by simultaneously targeting hypoxic cancer cells with HSP90 inhibitor and glycolysis inhibitor. | Clin Cancer Res | 2008 | https://conductscience.org/library/papers/18347186 | PubMed |
| 4 | 22854781 | A restricted cell population propagates glioblastoma growth after chemotherapy. | Nature | 2012 | https://conductscience.org/library/papers/22854781 | PubMed |
| 5 | 10365962 | Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. | Nature | 1999 | https://conductscience.org/library/papers/10365962 | PubMed |
| 6 | 27255896 | D-Peptides as Recognition Molecules and Therapeutic Agents. | Chem Rec | 2016 | https://conductscience.org/library/papers/27255896 | PubMed |
| 7 | 15729688 | The partial retro-inverso modification: a road traveled together. | Biopolymers | 2005 | https://conductscience.org/library/papers/15729688 | PubMed |
| 8 | 10880547 | Mitochondrion as a novel target of anticancer chemotherapy. | J Natl Cancer Inst | 2000 | https://conductscience.org/library/papers/10880547 | PubMed |
| 9 | 29088907 | Stem cells in cancer therapy: opportunities and challenges. | Oncotarget | 2017 | https://conductscience.org/library/papers/29088907 | PubMed |
| 10 | 28339833 | VDAC1 is a molecular target in glioblastoma, with its depletion leading to reprogrammed metabolism and reversed oncogenic properties. | Neuro Oncol | 2017 | https://conductscience.org/library/papers/28339833 | PubMed |
| 11 | 20037155 | Voltage-dependent anion channel 1-based peptides interact with Bcl-2 to prevent antiapoptotic activity. | J Biol Chem | 2010 | https://conductscience.org/library/papers/20037155 | PubMed |
| 12 | 18408762 | Methyl jasmonate binds to and detaches mitochondria-bound hexokinase. | Oncogene | 2008 | https://conductscience.org/library/papers/18408762 | PubMed |
| 13 | 21236661 | Apoptosis and oncogenesis: give and take in the BCL-2 family. | Curr Opin Genet Dev | 2011 | https://conductscience.org/library/papers/21236661 | PubMed |
| 14 | 17879147 | Warburg, me and Hexokinase 2: Multiple discoveries of key molecular events underlying one of cancers' most common phenotypes, the "Warburg Effect", i.e., elevated glycolysis in the presence of oxygen. | J Bioenerg Biomembr | 2007 | https://conductscience.org/library/papers/17879147 | PubMed |
| 15 | 16133861 | Mitochondria: A novel target for the chemoprevention of cancer. | Apoptosis | 2005 | https://conductscience.org/library/papers/16133861 | PubMed |
| 16 | 19461077 | The VDAC1 N-terminus is essential both for apoptosis and the protective effect of anti-apoptotic proteins. | J Cell Sci | 2009 | https://conductscience.org/library/papers/19461077 | PubMed |
| 17 | 18469866 | Disruption of the hexokinase-VDAC complex for tumor therapy. | Oncogene | 2008 | https://conductscience.org/library/papers/18469866 | PubMed |
| 18 | 10737788 | BH4 domain of antiapoptotic Bcl-2 family members closes voltage-dependent anion channel and inhibits apoptotic mitochondrial changes and cell death. | Proc Natl Acad Sci U S A | 2000 | https://conductscience.org/library/papers/10737788 | PubMed |
| 19 | 22589539 | Mediation of the antiapoptotic activity of Bcl-xL protein upon interaction with VDAC1 protein. | J Biol Chem | 2012 | https://conductscience.org/library/papers/22589539 | PubMed |
| 20 | 19094960 | Key regions of VDAC1 functioning in apoptosis induction and regulation by hexokinase. | Biochim Biophys Acta | 2009 | https://conductscience.org/library/papers/19094960 | PubMed |
Cited by32
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 51 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41622340 | VDAC2: an emerging pivotal and multifaceted regulator in tumor biology. | Apoptosis | 2026 | https://conductscience.org/library/papers/41622340 | PubMed |
| 40903965 | Role of voltage-dependent anion channel 1 in neurodegeneration: Mechanisms, implications, and therapeutic potential. | Neural Regen Res | 2026 | https://conductscience.org/library/papers/40903965 | PubMed |
| 40595352 | Decoding the diagnostic biomarkers of mitochondrial dysfunction related gene variants in pediatric T cell acute lymphoblastic leukemia. | Sci Rep | 2025 | https://conductscience.org/library/papers/40595352 | PubMed |
| 39905687 | The mitochondria as an emerging target of self-renewal in T-cell acute lymphoblastic leukemia. | Cancer Biol Ther | 2025 | https://conductscience.org/library/papers/39905687 | PubMed |
| 39684297 | Exploring Aerobic Energy Metabolism in Breast Cancer: A Mutational Profile of Glycolysis and Oxidative Phosphorylation. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39684297 | PubMed |
| 39334905 | VDAC1-Based Peptides as Potential Modulators of VDAC1 Interactions with Its Partners and as a Therapeutic for Cancer, NASH, and Diabetes. | Biomolecules | 2024 | https://conductscience.org/library/papers/39334905 | PubMed |
| 39272828 | Mitochondrial VDAC1 Silencing in Urethane-Induced Lung Cancer Inhibits Tumor Growth and Alters Cancer Oncogenic Properties. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/39272828 | PubMed |
| 38261660 | A novel MTORC2-AKT-ROS axis triggers mitofission and mitophagy-associated execution of colorectal cancer cells upon drug-induced activation of mutant KRAS. | Autophagy | 2024 | https://conductscience.org/library/papers/38261660 | PubMed |
| 37509279 | Therapeutic Targeting Potential of Novel Silver Nanoparticles Coated with Anti-CD20 Antibody against Chronic Lymphocytic Leukemia. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/37509279 | PubMed |
| 36982637 | Promising Strategy of mPTP Modulation in Cancer Therapy: An Emerging Progress and Future Insight. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36982637 | PubMed |
| 36900417 | Pro-Apoptotic and Anti-Cancer Activity of the Vernonanthura Nudiflora Hydroethanolic Extract. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/36900417 | PubMed |
| 36798470 | Emerging Landscape of Cell-Penetrating Peptide-Mediated Organelle Restoration and Replacement. | ACS Pharmacol Transl Sci | 2023 | https://conductscience.org/library/papers/36798470 | PubMed |
| 36330491 | Deregulated calcium signaling in blood cancer: Underlying mechanisms and therapeutic potential. | Front Oncol | 2022 | https://conductscience.org/library/papers/36330491 | PubMed |
| 36291596 | The Multicellular Effects of VDAC1 N-Terminal-Derived Peptide. | Biomolecules | 2022 | https://conductscience.org/library/papers/36291596 | PubMed |
| 36046435 | Overview of Ca2+ signaling in lung cancer progression and metastatic lung cancer with bone metastasis. | Explor Target Antitumor Ther | 2021 | https://conductscience.org/library/papers/36046435 | PubMed |
| 35887070 | Dysfunction of Mitochondria in Alzheimer's Disease: ANT and VDAC Interact with Toxic Proteins and Aid to Determine the Fate of Brain Cells. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35887070 | PubMed |
| 35397496 | Anti-cancer peptide-based therapeutic strategies in solid tumors. | Cell Mol Biol Lett | 2022 | https://conductscience.org/library/papers/35397496 | PubMed |
| 34880425 | Molecular mechanisms and consequences of mitochondrial permeability transition. | Nat Rev Mol Cell Biol | 2022 | https://conductscience.org/library/papers/34880425 | PubMed |
| 34703491 | An understanding of mitochondria and its role in targeting nanocarriers for diagnosis and treatment of cancer. | Asian J Pharm Sci | 2021 | https://conductscience.org/library/papers/34703491 | PubMed |
| 34135584 | Novel Strategies for Disrupting Cancer-Cell Functions with Mitochondria-Targeted Antitumor Drug-Loaded Nanoformulations. | Int J Nanomedicine | 2021 | https://conductscience.org/library/papers/34135584 | PubMed |
Genes75
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/29698587
GET https://conductscience.org/api/papers/v1/29698587/references?page=2